- Home
- BEDU vs OPTN Comparison
BEDU vs OPTN Comparison
Compare BEDU & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- OPTN
- Stock Information
- Founded
- BEDU 1994
- OPTN 2010
- Country
- BEDU United Kingdom
- OPTN United States
- Employees
- BEDU N/A
- OPTN N/A
- Industry
- BEDU Other Consumer Services
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- OPTN Health Care
- Exchange
- BEDU Nasdaq
- OPTN Nasdaq
- Market Cap
- BEDU 44.9M
- OPTN 55.4M
- IPO Year
- BEDU 2017
- OPTN 2017
- Fundamental
- Price
- BEDU $1.51
- OPTN $9.15
- Analyst Decision
- BEDU
- OPTN Hold
- Analyst Count
- BEDU 0
- OPTN 3
- Target Price
- BEDU N/A
- OPTN $9.00
- AVG Volume (30 Days)
- BEDU 17.8K
- OPTN 171.1K
- Earning Date
- BEDU 04-21-2025
- OPTN 03-26-2025
- Dividend Yield
- BEDU N/A
- OPTN N/A
- EPS Growth
- BEDU N/A
- OPTN N/A
- EPS
- BEDU N/A
- OPTN N/A
- Revenue
- BEDU $231,461,038.00
- OPTN $78,226,000.00
- Revenue This Year
- BEDU N/A
- OPTN $13.42
- Revenue Next Year
- BEDU N/A
- OPTN $38.54
- P/E Ratio
- BEDU N/A
- OPTN N/A
- Revenue Growth
- BEDU N/A
- OPTN 10.20
- 52 Week Low
- BEDU $1.35
- OPTN $4.82
- 52 Week High
- BEDU $2.42
- OPTN $22.35
- Technical
- Relative Strength Index (RSI)
- BEDU 44.17
- OPTN 81.43
- Support Level
- BEDU $1.45
- OPTN $9.12
- Resistance Level
- BEDU $2.15
- OPTN $9.35
- Average True Range (ATR)
- BEDU 0.23
- OPTN 0.25
- MACD
- BEDU 0.00
- OPTN 0.35
- Stochastic Oscillator
- BEDU 20.00
- OPTN 89.46
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.